Nithi Thinrungroj

Nithi Thinrungroj

Auto-generated profile, based on publicly available information

Nithi Thinrungroj

Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
IKIsariyaphong Kotikula
Isariyaphong Kotikula
NTNithi Thinrungroj
Nithi Thinrungroj
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
PKPhuripong Kijdamrongthum
Phuripong Kijdamrongthum
ALApinya Leerapun
Apinya Leerapun
OPOng‐Ard Praisontarangkul
Ong‐Ard Praisontarangkul

30 April 2020 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
SPSiripa Puasripun
Siripa Puasripun
NTNithi Thinrungroj
Nithi Thinrungroj
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
PKPhuripong Kijdamrongthum
Phuripong Kijdamrongthum
ALApinya Leerapun
Apinya Leerapun
OPOng-Ard Praisontarangkul
Ong-Ard Praisontarangkul
Siripa Puasripun, Nithi Thinrungroj, Kanokwan Pinyopornpanish, Phuripong Kijdamrongthum, Apinya Leerapun, Taned Chitapanarux, Satawat Thongsawat, and Ong-Ard Praisontarangkul. J Neurogastroenterol Motil 2020;26:259-66. https://doi.org/10.5056/jnm19186

11 December 2020 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PCPanjit Chieosilapatham
Panjit Chieosilapatham
NPNayanunt Prinyaroj
Nayanunt Prinyaroj
SJSirinda Jamjanya
Sirinda Jamjanya
SKSalin Kiratikanon
Salin Kiratikanon
NTNithi Thinrungroj
Nithi Thinrungroj
MCMati Chuamanochan
Mati Chuamanochan

14 March 2024 in JGH Open
Verified
Journal Article
Open access
TKThansita Kamolsripat
Thansita Kamolsripat
NTNithi Thinrungroj
Nithi Thinrungroj
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
PKPhuripong Kijdamrongthum
Phuripong Kijdamrongthum
ALApinya Leerapun
Apinya Leerapun
SPSuwalee Pojchamarnwiputh
Suwalee Pojchamarnwiputh
Background and Aim: Functional dyspepsia (FD) remains a therapeutic challenge, and the efficacy of antispasmodic agents as adjunctive therapy is not well established. This study aimed to evaluate the efficacy and safety of pinaverium bromide added to omeprazole in treating refractory FD.Methods: We conducted a randomized, placebo‐controlled trial in patients with refractory dyspepsia. Participants were randomly assigned to receive pinaverium (50 mg, 3 times/day, n = 36) or placebo (n = 36) in addition to omeprazole for 8 weeks. The primary endpoint was the responder rate for adequate relief. Secondary outcomes included the Global Overall Symptom Scale (GOSS), quality of life, and safety profile.Results: No statistically significant differences were observed in the adequate relief response rate between the pinaverium bromide and control group at week 2 (58.3% vs. 62.9%, P = 0.697), week 4 (62.9% vs. 78.1%, P = 0.173), week 6 (64.7% vs. 75.0%, P = 0.363), and week 8 (64.7% vs. 75.0%, P = 0.363). Additionally, there were no significant differences observed in the decline of symptom score between the two groups at week 4 (8.4 ± 7.6 vs. 7.7 ± 7.1, P = 0.702) and week 8 (10.9 ± 8.2 vs. 8.4 ± 7.2, P = 0.196). Similarly, there were no significant differences in terms of quality of life between the two groups. Adverse event rates were also comparable between the two groups.Conclusion: Pinaverium bromide was found to be safe in the treatment of refractory dyspepsia, but it did not demonstrate a significant benefit in improving symptoms.

24 May 2025 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
NMNuttida Manoros
Nuttida Manoros
NTNithi Thinrungroj
Nithi Thinrungroj
WWWasuwit Wanchaitanawong
Wasuwit Wanchaitanawong
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
PKPhuripong Kijdamrongthum
Phuripong Kijdamrongthum
OPOng-Ard Praisontarangkul
Ong-Ard Praisontarangkul
Objective To compare water-assisted colonoscopy (WAC) using the water immersion technique with conventional carbon dioxide insufflation colonoscopy (CC) in novice endoscopists, focusing on procedure time, safety and learning curves. Methods We conducted a prospective, randomised (1:1), single-centre trial at Chiang Mai University Hospital, Thailand. Six gastroenterology fellows with <150 prior colonoscopies received standardised training before performing elective screening colonoscopies using either WAC or CC techniques. Patients were randomly assigned to WAC or CC groups. The primary outcome was caecal intubation time (CIT). Secondary outcomes included technical failure, procedural difficulty, patient discomfort, complications, withdrawal time and adenoma detection rate (ADR). Results Of 250 randomised patients, 230 completed the protocol (WAC, n=113; CC, n=117). Mean CIT was comparable between groups (10.6±4.2 min vs 9.8±3.9 min; p=0.35). Technical failure occurred in 6.2% of WAC and 5.1% of CC procedures, with no significant differences in procedural difficulty ratings, analgesic requirements or patient discomfort scores. ADR was similar between arms (40.7% vs 33.3%; p=0.25). Learning curves demonstrated parallel, progressive reductions in CIT among fellows in both groups. Conclusion WAC is a safe and effective alternative to CC for novice endoscopists, with similar procedure times, learning curves and safety profiles. These findings support the inclusion of WAC in gastroenterology training programmes. Trial registration number TCTR20230324001.

23 March 2021 in Clinical Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
TPTharadol Poolthawee
Tharadol Poolthawee
PKPhuripong Kijdamrongtham
Phuripong Kijdamrongtham
NTNithi Thinrungroj
Nithi Thinrungroj